These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30877795)

  • 21. Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
    Hutter M; Broecker S; Kneisel S; Franz F; Brandt SD; Auwarter V
    Curr Pharm Biotechnol; 2018; 19(2):144-162. PubMed ID: 29745330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens.
    Wohlfarth A; Scheidweiler KB; Castaneto M; Gandhi AS; Desrosiers NA; Klette KL; Martin TM; Huestis MA
    Clin Chem Lab Med; 2015 Feb; 53(3):423-34. PubMed ID: 25263309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vitro Metabolic Profile Elucidation of Synthetic Cannabinoid APP-CHMINACA (PX-3).
    Presley BC; Logan BK; Jansen-Varnum SA
    J Anal Toxicol; 2020 Apr; 44(3):226-236. PubMed ID: 31665324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tentative identification of the metabolites of (1-(cyclohexylmethyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone, and the product of its thermal degradation, by in vitro and in vivo methods.
    Grigoryev A; Kavanagh P; Labutin A; Pechnikov A; Dowling G; Shevyrin V; Krupina N
    Drug Test Anal; 2019 Sep; 11(9):1387-1402. PubMed ID: 31243890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine.
    Staeheli SN; Veloso VP; Bovens M; Bissig C; Kraemer T; Poetzsch M
    Drug Test Anal; 2019 Sep; 11(9):1369-1376. PubMed ID: 31219237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    Yeter O; Ozturk YE
    Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.
    Scheidweiler KB; Jarvis MJ; Huestis MA
    Anal Bioanal Chem; 2015 Jan; 407(3):883-97. PubMed ID: 25224637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vivo Metabolites of AB-PINACA in Solid Tissues Obtained from Its Abuser: Comparison with In Vitro Experiment.
    Minakata K; Hasegawa K; Yamagishi I; Nozawa H; Suzuki M; Kitamoto T; Suzuki O; Watanabe K
    J Anal Toxicol; 2021 Jan; 44(9):1027-1035. PubMed ID: 32232365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Novel Psychoactive Substance Cumyl-CH-MEGACLONE: Human Phase-I Metabolism, Basic Pharmacological Characterization and Comparison to Other Synthetic Cannabinoid Receptor Agonists with a γ-Carboline-1-One Core.
    Haschimi B; Giorgetti A; Mogler L; Nagy TZ; Kramer S; Halter S; Boros S; Dobos A; Hidvégi E; Auwärter V
    J Anal Toxicol; 2021 Mar; 45(3):277-290. PubMed ID: 32514544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involuntary 5F-ADB-related intoxication following e-cigarette use.
    Salle S; Sevestre C; Richeval C; Hakim F; Allorge D; Gaulier JM
    Int J Legal Med; 2021 Jul; 135(4):1467-1470. PubMed ID: 33765158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eutylone Intoxications-An Emerging Synthetic Stimulant in Forensic Investigations.
    Krotulski AJ; Papsun DM; Chronister CW; Homan J; Crosby MM; Hoyer J; Goldberger BA; Logan BK
    J Anal Toxicol; 2021 Feb; 45(1):8-20. PubMed ID: 33325503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS.
    Borg D; Tverdovsky A; Stripp R
    J Anal Toxicol; 2017 Jan; 41(1):6-16. PubMed ID: 27681343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: Update of the German situation in summer 2018.
    Ernst L; Langer N; Bockelmann A; Salkhordeh E; Beuerle T
    Forensic Sci Int; 2019 Jan; 294():96-102. PubMed ID: 30497049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry.
    Presley BC; Logan BK; Jansen-Varnum SA
    Drug Test Anal; 2019 Aug; 11(8):1264-1276. PubMed ID: 31108568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens.
    Arntson A; Ofsa B; Lancaster D; Simon JR; McMullin M; Logan B
    J Anal Toxicol; 2013 Jun; 37(5):284-90. PubMed ID: 23625703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid Identification of MDMB-CHMINACA Metabolites Using Zebrafish and Human Liver Microsomes as the Biotransformation System by LC-QE-HF-MS.
    Xu DQ; Dai Y; Zhang WF; Wang JF; Wang YY; Zhang Y; Zhao QL; Li X
    J Anal Toxicol; 2021 Jan; 44(9):1012-1026. PubMed ID: 32020177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of urinary metabolites of XLR-11 by liquid chromatography-quadrupole time-of-flight mass spectrometry.
    Jang M; Kim IS; Park YN; Kim J; Han I; Baeck S; Yang W; Yoo HH
    Anal Bioanal Chem; 2016 Jan; 408(2):503-16. PubMed ID: 26514671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue.
    Sobolevsky T; Prasolov I; Rodchenkov G
    Drug Test Anal; 2015 Feb; 7(2):131-42. PubMed ID: 25428705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists 2F-QMPSB and SGT-233 Including Isozyme Mapping and Carboxylesterases Activity Testing.
    Richter MJ; Wagmann L; Brandt SD; Meyer MR
    J Anal Toxicol; 2023 Jan; 46(9):e198-e206. PubMed ID: 36083120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.